Sage Journals: Discover world-class research

Abstract

Background: COVID-19 patients experience respiratory muscle damage, leading to reduced respiratory function and functional capacity often requiring mechanical ventilation which further increases susceptibility to muscle weakness. Inspiratory muscle training (IMT) may help mitigate this damage and improve respiratory function and functional capacity. Methods: We studied the effects of IMT on muscle damage biomarkers, respiratory function, and functional capacity in COVID-19 recovered young adults, successfully weaned from mechanical ventilation. Participants were randomly allocated to either an IMT (n = 11) or control (CON; n = 11) intervention for 4 weeks. The IMT group performed 30 dynamic inspiratory efforts twice daily, at 50% of their maximal inspiratory mouth pressure (P_Mmax) while the CON group performed 60 inspiratory efforts at 10% of p_Mmax daily. Serum was collected at baseline, week two, and week four to measure creatine kinase muscle-type (CKM), fast skeletal troponin-I (sTnI) and slow sTnI. Results: Time × group interaction effects were observed for CKM and slow sTnI, but not for fast sTnI. Both were lower at two and 4 weeks for the IMT compared to the CON group, respectively. Time × group interaction effects were observed for forced expiratory volume in 1s, forced vital capacity, P_Mmax and right- and left-hand grip strength. These were higher for the IMT compared to the CON group. Conclusion: Four weeks of IMT decreased muscle damage biomarkers and increased respiratory function and grip strength in recovered COVID-19 patients after weaning from mechanical ventilation.

Keywords

Biomarkers muscle damage inspiratory muscle training COVID-19

Introduction

Coronavirus disease (COVID-19) can reduce respiratory muscle function and functional capacity.¹ This can be through direct action of the virus (severe acute respiratory syndrome coronavirus-2) in the respiratory muscles causing muscle cell damage, inflammation and impaired muscle function^2,3 and the resultant respiratory failure and increased work of breathing may necessitate mechanical ventilation.⁴ Mechanical ventilation, while a life-saving intervention in patients with severe respiratory failure,⁵ may also lead to disuse atrophy, weakness and damage to the respiratory muscles.^6,7 This can reduce respiratory function and functional capacity after the patient is weaned from mechanical ventilation.^6,7 COVID-19 causes a distinct pattern of lung damage, characterized by diffuse alveolar damage and impaired gas exchange.^2,3 This unique pathology leads to persistent respiratory impairments, including reduced lung compliance, decreased inspiratory muscle strength, and impaired gas exchange efficiency, even after patients have been weaned from mechanical ventilation.^2,3,8

As the respiratory muscles play an essential role in ventilation, damage to these muscles may have serious consequences and can lead to respiratory muscle dysfunction.^9,10 This dysfunction can manifest as dyspnea and exercise intolerance through to ventilatory failure.¹⁰ Previous studies have shown that the amount of respiratory muscle damage can be assessed by measuring concentrations of specific skeletal muscle damage biomarkers including creatine kinase muscle type (CKM), and slow and fast skeletal troponin I (sTnI) isoforms.^11,12

Inspiratory muscle training (IMT) may help to restore muscle coordination lost during mechanical ventilation, by improving motor unit synchronization, resulting in more effective and efficient respiratory muscle function.^13,14 This improved efficiency following training may result in lower concentrations of biomarkers of muscle damage. There is some evidence that 2 weeks of IMT may improve pulmonary function, dyspnea, functional capacity and Quality of life (QoL) in recovered COVID-19 patients after weaning from mechanical ventilation.¹⁵ However, a placebo or sham IMT group was not used in this study which weakens internal validity and risks participant bias. Whether IMT compared to a sham IMT control group could reduce biomarkers of muscle damage and improve respiratory function and functional capacity in recovered COVID-19 patients after weaning from mechanical ventilation is unknown.

Accordingly, we investigated the effects of IMT on biomarkers of muscle damage, respiratory function and functional capacity in recovered COVID-19 patients after weaning from mechanical ventilation. We hypothesized that IMT would reduce muscle damage and improve respiratory function and functional capacity compared to a control group using sham IMT.

Methods

Participants

Twenty-two COVID-19 recovered adults (Table 1), successfully weaned from mechanical ventilation within previous 4 weeks and having a COVID-19 negative report were recruited from University of Lahore Teaching Hospital, Lahore, Pakistan. The exclusion criteria were unsuccessfully weaned from mechanical ventilation; aged <18 or >40 years; a body mass index (BMI) of <18.5 or >30 kg/m²; current cigarette smoker; history of cardiopulmonary disease; or known disease and/or signs or symptoms of disease before COVID-19 who may be at a higher risk of an adverse event due to testing and/or IMT. All participants provided written, informed consent. All study procedures were approved by The University of Lahore Teaching Hospital and by The University of Southern Queensland Human Research Ethics Committee (H21REA171), which adheres to the Declaration of Helsinki.

Table 1.

Anthropometrics and respiratory function for the inspiratory muscle training (IMT) and control (CON) groups at baseline. Values are mean ± SD.

Variable	IMT (n = 11)	CON (n = 11)	p value
Age (years)	34 ± 6	32 ± 7	0.47
Sex (male/female)	8/3	7/4
Height (cm)	171 ± 5.0	170 ± 5	0.76
Body mass (kg)	73.2 ± 6.6	75.8 ± 8.3	0.44
Body mass index (kg/m²)	25.2 ± 1.5	26.2 ± 2.4	0.22
Days on mechanical ventilation	6.5 ± 3.4	8.1 ± 3.6	0.29
Baseline testing (days after weaning from mechanical ventilation)	19.5 ± 4.1	18.9 ± 5.3	0.80
FVC (% predicted)	79 ± 6	74 ± 6	0.31
FEV₁ (% predicted)	78 ± 5	75 ± 6	0.08
FEV₁/FVC (% predicted)	97 ± 3	98 ± 4	0.32
P_Mmax (% predicted)	70 ± 13	72 ± 16	0.54

FVC, forced vital capacity; FEV₁, forced expiratory volume in 1 s; P_Mmax, maximal inspiratory mouth pressure.

Experimental design

The study adopted a single-blind, randomized controlled design. Participants attended the physiotherapy department of University of Lahore Teaching Hospital on four separate visits. All the participants were outpatients at the time of recruitment. The first was a screening visit where participants completed the Exercise and Sports Science Australia Adult Pre-Exercise Screening System.¹⁶ Subsequently, participants provided informed consent and height, body mass, pulmonary function, and maximal inspiratory mouth pressure (P_Mmax) were assessed. Participants were then randomly, and equally divided into either an IMT or control (CON) group using Altman’s minimization method (prioritizing BMI and sex) to ensure that the groups were balanced.¹⁷ During the second visit, participants had a blood sample taken and undertook questionnaires for dyspnea using the MRC Dyspnea Scale¹⁸ and QoL, and undertook a six-minute walk test (6MWT), grip strength test and sit-to-stand test and were familiarized with the IMT or CON interventions. During visits three and four, participants repeated same assessments as in visit two. Visits one and two were separated by 24 h and visits two, three and four by 2 weeks.

Anthropometrics

Participants’ height was measured to the nearest 1 cm using a wall-mounted telescopic stadiometer (Seca220; Vogel & Halke, Hamburg, Germany) and body mass to the nearest 100 g using an electronic scale (Tanita Ultimate Scale 2000; Tanita, Tokyo, Japan).

Respiratory function

Participants performed standardized forced vital capacity (FVC) maneuvers using a spirometer (Spirolab; Medical International Research, New Berlin, WI, USA) according to published guidelines.¹⁹ P_Mmax was assessed using KH2 model IMT device (POWERbreathe International Ltd^®, Warwickshire, UK) whilst participants were seated and wearing a nose clip and was initiated from residual volume. Repeat efforts were separated by 30 s and were performed until three serial measures differed by no more than 10% or 10 cmH₂O, whichever was smallest.²⁰ Participants performed a minimum of five and a maximum of 10 efforts. The average of three highest values recorded were used for subsequent analysis. Predicted values for pulmonary volumes and capacities are from Quanjer et al.²¹ and for P_Mmax are from Wilson et al.²²

Quality of life, handgrip strength, sit to stand and six-minute walk test

QoL was assessed utilizing the Euro Quality 5-Dimensions-3Levels (EQ-5D-3 L) questionnaire.^23,24 Handgrip strength was determined using hand dynamometry (Jamar Digital Plus; Lafayette Instruments, Lafayette, IN, USA) as previously described.²⁵ One-minute sit to stand testing was performed with a chair of standard height and without armrests. The participant was seated upright on the chair positioned against a wall. The participants were required to get up from this chair with the legs straight and sit back down whilst continuing the repetitions as fast as possible within 1 min.²⁶ Exercise performance was assessed by using a 6MWT according to published guidelines.^27,28 Predicted values for the 6MWT are from Rao et al.²⁹

Blood sampling and enzyme-linked immunosorbent assays

Twenty mL of venous blood was collected at each time point from an antecubital vein using a suitable method (either evacuated tube system or winged infusion) into serum separator tubes (BD Vacutainer^® SST™ Tubes; Franklin Lakes, NJ, USA). The serum was separated, aliquoted and stored at −80°C until biochemical assays were performed. Enzyme-linked immunosorbent assays were performed for serum biomarkers using commercially available kits: Human CKM (Catalog No. RK01117 Abclonal, Woburn MA, USA); Fast sTnI (Catalog No. RK02421 Abclonal, Woburn MA, USA); and Slow sTnI (Catalog No. RK02420 Abclonal, Woburn MA, USA). ELISAs were performed by following manufacturers’ instructions for each specific kit. To minimize the effect of inter-assay variation, markers from both the IMT and CON groups were measured using the same assay plate.

Inspiratory muscle training and control interventions

The intervention lasted 4 weeks. The IMT and CON group were told they were a part of ‘respiratory muscle strength training’ OR ‘respiratory muscle endurance training’ intervention respectively. Both IMT and CON groups performed their respective training with an inspiratory pressure-threshold device (POWERbreathe Classic series 1st generation; Gaiam Ltd, Southam, UK). The IMT group performed 30 consecutive dynamic inspiratory efforts twice daily with initial training load set at 50% P_Mmax. Thereafter, participants were instructed to periodically increase the load so that 30 maneuvers could only just be completed. Each inspiratory effort was to be initiated from residual volume, and participants were asked to strive to maximize tidal volume. This regimen is known to be effective in eliciting an adaptive response.^30–32 The CON group trained at a fixed intensity of 10% of P_Mmax once per day for a total of 60 repetitions, 5 days/week. Both groups performed one supervised session at the start of intervention and during week two of intervention to monitor the appropriateness of their training technique and intensity. Compliance was assessed using a register of completed sessions.

Statistical analysis

Statistical analyses were performed using SPSS 25 for Windows (IBM, Chicago, IL, USA). An initial power calculation was performed on the basis of our previous work,¹¹ showing that twelve participants would be required to demonstrate a 10% reduction in sTnI with an alpha of 0.05. Normality of the data was assessed by visual inspection of histograms. The data from both groups were analyzed using a two-way analysis of variance (ANOVA) procedure to determine the effects of ‘time’ (baseline, two and 4 weeks) and ‘group’ (IMT vs CON). Following significant interaction effects, pairwise comparisons were made using the Bonferroni method (adjustments for multiple comparisons). Statistical significance was set at p < 0.05. Results are presented as means ± SD.

Results

Participant characteristics

Figure 1 shows the CONSORT participant flow diagram. Compliance with the interventions was good with 78 ± 4% and 91 ± 5% of the IMT and CON sessions completed, respectively. There were no differences in baseline participant characteristics between the groups (Table 1).

Figure 1.

The CONSORT flow diagram of the study.

Respiratory function and functional capacity

A two-way ANOVA revealed time × group interaction effects for forced expiratory volume in 1 s (FEV₁; p = 0.007), FVC (p = 0.002) and P_Mmax (p = 0.001), but not for FEV₁/FVC (p = 0.405). FVC was higher for the IMT compared to the CON group at week two (p = 0.022) and week four (p = 0.015) of the intervention. Both FEV₁ and P_Mmax were higher (p < 0.05) for the IMT compared to CON group at week four of the intervention (Table 2).

Table 2.

Respiratory function and functional capacity for the inspiratory muscle training (IMT) and control (CON) groups at baseline, week two and week four. Values are mean ± SD.

Variable	Group	Baseline	Week 2	Week 4
FEV₁ (L)	IMT	2.92 ± 0.45	3.06 ± 0.49	3.25 ± 0.53*
FEV₁ (L)	CON	2.68 ± 0.32	2.77 ± 0.31	2.87 ± 0.31
FEV₁ (% predicted)	IMT	80 + 4*	84 + 5*	89 + 5*
FEV₁ (% predicted)	CON	75 + 5	77 + 7	81 + 7
FVC (L)	IMT	3.53 ± 0.54	3.81 ± 0.61*	4.04 ± 0.66*
FVC (L)	CON	3.15 ± 0.36	3.29 ± 0.35	3.45 ± 0.35
FVC (% predicted)	IMT	80 + 6	87 + 6*	92 + 5*
FVC (% predicted)	CON	76 + 7	77 + 7	81 + 8
FEV₁/FVC	IMT	0.83 ± 0.03	0.80 ± 0.02	0.80 ± 0.01
FEV₁/FVC	CON	0.85 ± 0.02	0.84 ± 0.02	0.83 ± 0.02
FEV₁/FVC (% predicted)	IMT	99 + 3	96 + 3	97 + 2
FEV₁/FVC (% predicted)	CON	97 + 5	95 + 3	96 + 6
P_Mmax (cmH₂O)	IMT	68 ± 6	75 ± 7	79 ± 7*
P_Mmax (cmH₂O)	CON	67 ± 6	71 ± 7	73 ± 6
P_Mmax (% predicted)	IMT	70 ± 13	77 + 15	82 + 9
P_Mmax (% predicted)	CON	72 + 16	75 + 14	78 + 17
6MWTD (m)	IMT	333 ± 31	366 ± 38	378 ± 40
6MWTD (m)	CON	317 ± 55	331 ± 58	339 ± 60
6MWTD (% predicted)	IMT	65.2 ± 4.7	71.8 ± 5.2	74 ± 5.5
6MWTD (% predicted)	CON	61.9 ± 9.8	64.5 ± 10.3	67 ± 10.7
Grip strength right hand (kg)	IMT	33 ± 6	39 ± 8*	45 ± 11*
Grip strength right hand (kg)	CON	30 ± 4	34 ± 4	36 ± 5
Grip strength left hand (kg)	IMT	31 ± 6	35 ± 8*	39 ± 8*
Grip strength left hand (kg)	CON	27 ± 3	30 ± 3	32 ± 3
Sit to stand (repetitions/min)	IMT	24 ± 3	27 ± 3	30 ± 4
Sit to stand (repetitions/min)	CON	24 ± 4	26 ± 4	28 ± 5

FEV₁, forced expiratory volume in 1 s; FVC, forced vital capacity; P_Mmax, maximal inspiratory mouth pressure; 6MWTD, six-minute walk test distance. *Significantly different between IMT and CON (p < 0.05).

A two-way ANOVA revealed time × group interaction effects for the distance covered during 6MWT (p = 0.001), sit to stands repetitions (p < 0.001) and right-hand (p < 0.001) and left-hand (p = 0.001) grip strength. There were no pairwise differences between the IMT and CON groups for the 6MWT distance and sit to stand repetitions. Right and left-hand grip strength was higher for the IMT compared to the CON group at week two (p = 0.05 p = 0.031) and week four (p = 0.013, p = 0.012) during the intervention.

Quality of life and dyspnea

A two-way ANOVA revealed time × group interaction effects for QoL score on the visual analogue scale (p = 0.001). QoL score on the visual analogue scale was higher for the IMT compared to the CON group at week two (p = 0.012) and week four (p < 0.001) during the intervention. None of the five dimensions of QoL questionnaire including self-care (p = 0.190), mobility (p = 0.160), anxiety/depression (p = 0.220), pain/discomfort (p = 0.230) and usual activity (p = 0.390) showed significant time × group interaction effects. There were no time × group interaction effects for dyspnea (p = 0.418) (Table 3).

Table 3.

Quality of life (visual analog scale and Euro Quality 5-Dimensions-3Levels (EQ-5D-3L)) and dyspnea (MRC Dyspnea Scale) for the inspiratory muscle training (IMT) and control (CON) groups at baseline, week two and week four. Values are mean ± SD.

Variable	Group	Baseline	Week 2	Week 4
Visual analog scale	IMT	47 ± 6	60 ± 8*	72 ± 7*
Visual analog scale	CON	42 ± 7	51 ± 7	59 ± 7
Self-care	IMT	2.00 ± 0.45	1.18 ± 0.40	1.00 ± 0.00
Self-care	CON	2.27 ± 0.47	1.82 ± 0.40	1.36 ± 0.50
Mobility	IMT	2.00 ± 0.00	1.18 ± 0.40	1.09 ± 0.30
Mobility	CON	2.09 ± 0.30	1.64 ± 0.50	1.27 ± 0.47
Anxiety/depression	IMT	1.91 ± 0.54	1.55 ± 0.52	1.18 ± 0.40
Anxiety/depression	CON	2.18 ± 0.40	2.09 ± 0.30	1.82 ± 0.60
Pain/discomfort	IMT	1.73 ± 0.47	1.18 ± 0.40	1.09 ± 0.30
Pain/discomfort	CON	1.91 ± 0.30	1.64 ± 0.50	1.18 ± 0.40
Usual activity	IMT	2.00 ± 0.00	1.45 ± 0.52	1.09 ± 0.30
Usual activity	CON	2.00 ± 0.00	1.64 ± 0.50	1.36 ± 0.50
Dyspnea	IMT	3.36 ± 0.50	2.18 ± 0.40	1.45 ± 0.52
Dyspnea	CON	3.64 ± 0.50	2.73 ± 0.65	2.00 ± 0.63

*Significantly different between IMT and CON (p < 0.05).

Muscle damage biomarkers

A two-way ANOVA revealed time × group interaction effects for CKM (p < 0.001) and slow sTnI (p = 0.030). Both were lower for the IMT compared to the CON group at week two (p = 0.001, p = 0.002) and week four (p = 0.020, p = 0.001) during the intervention. There were no significant time × group interaction effects for fast sTnI (p = 0.130) (Figure 2).

Figure 2.

Serum slow skeletal troponin I (sTnI) (A), fast sTnI (B) and creatine kinase muscle type (CKM; C) for the inspiratory muscle training (IMT) and control (CON) groups at baseline, week two and week four. Values are means ± SD. *Significantly different between IMT and CON (p < 0.05).

Discussion

Main findings

The main findings were that compared to the CON group, 4 weeks of IMT resulted in a reduction in muscle damage biomarkers sTnI and CKM. IMT improved pulmonary function and inspiratory muscle strength, measured through P_Mmax. Four weeks of IMT also resulted in an increase in some components of physical functional capacity, as indicated by increased hand grip strength.

Muscle damage biomarkers

To our knowledge, we are the first to report the effects of IMT on muscle damage biomarkers including CKM, fast sTnI, and slow sTnI in COVID-19 recovered patients, who had been weaned from mechanical ventilation. Our results showed that serum concentrations of CKM, fast sTNI, and slow sTNI were higher at baseline in recovered COVID-19 patients who had been weaned from mechanical ventilation in the last 4 weeks than concentrations observed in healthy individuals.^11,12 The results for the serum concentrations of CKM, fast sTNI, and slow sTNI were also similar to those reported in patients being weaned from mechanical ventilation³³ and the CKM results from patients with COVID-19.³⁴

Previous studies^11,12 have reported that these markers are more sensitive and specific biomarkers to evaluate respiratory muscle damage following conditions that elevate inspiratory muscle work or activity and causes respiratory muscle damage (i.e., inspiratory pressure threshold loading; ITL). Respiratory muscle damage may occur during and following excessive loading, which exceeds the usual requirements of the muscle. Excessive loading can be categorized in two ways - overload or overactivity.⁹ In respiratory disease, the respiratory muscles can experience both overload and overactivity because each breath may require a higher inspiratory muscle force and a higher breathing frequency (i.e., number of respiratory muscle contractions). ITL has been used previously to load respiratory muscles beyond their normal capacity and this loading was intended to produce respiratory muscle damage.^11,12 ITL-induced respiratory muscle damage could be particular to just a few macromolecules of muscle tissue, or could result in small tears in the sarcolemma, z-disk, basal lamina, or supportive connective tissues, and damage to the cytoskeleton and contractile elements.^9,12

Our results showed that the serum concentrations of CKM, fast and slow sTnI were higher at baseline in recovered COVID-19 patients who had been weaned from mechanical ventilation in the last 4 weeks than concentrations reported in healthy individuals.^11,12,35 COVID-19 patients may experience respiratory muscle damage either through direct viral invasion of the respiratory muscles causing muscle cell damage, inflammation and impaired muscle function.^1–3 The resultant respiratory failure and increased work of breathing may necessitate mechanical ventilation.⁴ COVID-19 patients, weaned from mechanical ventilation, may have been experiencing respiratory muscle weakness and damage due to COVID-19 and the effects of mechanical ventilation.

Both the IMT and CON groups observed reduction in the concentrations of muscle damage biomarkers, but IMT resulted in a greater reduction in CKM and slow sTnI compared to the CON group. The decrease in all biomarkers in both groups could be due to the natural recovery of muscles post-ventilation, but the significantly greater decrease in the IMT group compared to the CON group could be attributed to the IMT intervention. IMT has been found to be beneficial in the recovery from mechanical ventilation-induced respiratory muscle dysfunction by increasing respiratory muscle strength and endurance.^36,37 IMT might have helped to restore the muscle coordination lost during mechanical ventilation by potentially training the muscles to work together in a synchronized manner, possibly resulting in more effective and efficient respiratory muscle function.^13,14 This improved efficiency following training may have resulted in lower concentrations of biomarkers of muscle damage (CKM and slow sTnI). IMT can also improve overall metabolic function and could enhance the body’s ability to clear metabolites.^38,39 This could contribute to a more rapid clearance of muscle damage biomarkers from the bloodstream over time and IMT could have potentially accelerated their removal. This mechanism should remove all biomarkers, but just a significant removal was observed in slow sTnI and CKM and not fast sTnI.

Our findings may also indicate that our IMT protocol preferentially targeted slow fibers, whereas this protocol had less effect on fast fibers (i.e., fast sTnI). This could be explained on results presented by another study analyzing the structural adaptations and physiological outcomes of IMT in patients with chronic obstructive pulmonary disease (COPD).⁴⁰ The proportion of type I fibers (∼38%) and the size of type II fibers (21%) of the external intercostal muscles increase after IMT in COPD patients.⁴⁰ These findings establish that the external intercostal muscles of patients with COPD have the capacity to express differential structural remodeling after IMT. It must be noted though that the IMT protocols used by Ramirez-Sarmiento et al.⁴⁰ and the present study differ, and this potentially impacts the structural changes that may be observed. The participants in the Ramirez-Sarmiento et al.⁴⁰ study underwent 30 min of IMT that included intermittent IMT for 3 min with 2 min rest periods, starting at 60% P_Mmax, for 5 days per week over 5 weeks. In contrast, our study used a 4 week intervention where the IMT group performed 30 consecutive dynamic inspiratory efforts twice daily, starting at 50% of P_Mmax and adjusting the load periodically.

Respiratory function

The P_Mmax at baseline and throughout the intervention indicates inspiratory muscle weakness in both the IMT and CON groups.⁴¹ We observed an increase in FEV₁, FVC and P_Mmax, but not FEV₁/FVC following IMT. FVC was higher for the IMT compared to the CON group at weeks two and four during the intervention. FEV₁ and P_Mmax were higher for the IMT compared to the CON group at week four during the intervention. IMT may have improved lung function by increasing the strength and endurance of the inspiratory muscles resulting in an increase in total lung capacity.⁴² In healthy individuals, the principal limitation on total lung capacity is inspiratory muscle strength. Thus, if the inspiratory muscles are stronger, they can oppose the combined elastic recoil of the chest wall and lungs to a greater extent, and thereby a higher end-inspiratory lung volume can be achieved at full inflation (i.e., total lung capacity). Also, with a larger initial lung volume, there is slightly greater tethering of the airway, which would also facilitate a higher FEV₁.^43,44 Our findings support a recent study that found an increase in P_Mmax, FVC and FEV₁ following 2 weeks of IMT in COVID-19 patients following their weaning from mechanical ventilation.¹⁵ We recognize that patients recovering from COVID-19 would also regain their respiratory muscle function without IMT.⁴⁵ Nevertheless, based upon our findings, IMT may have accelerated this recovery.

Functional capacity

We observed time × group interaction effects for the distance covered during 6MWT, sit to stands repetitions and right- and left-hand grip strength. However, there were no pairwise differences between the IMT and CON groups for the 6MWT distance and sit to stand repetitions. Our results suggest that as little as 4 weeks of IMT can improve grip strength, but this may not have been a long enough duration to improve 6MWT distance and sit to stand repetitions. The 6MWT and sit to stand tests are more complex physical function tests compared to hand grip strength. It is unclear why grip strength was improved following IMT. However, we speculate that improved motor unit synchronization post IMT may result in improved neuromuscular recruitment patterns and postural stability.^46,47

Quality of life and dyspnea

We observed a higher QoL score for the VAS for the IMT compared to the CON group at week two and week four during the intervention. However, none of the five dimensions of QoL measured using the EQ-5D-3 L changed significantly during intervention. Abodonya et. al¹⁵ reported that total QoL VAS score in EQ-5D-3 L questionnaire was increased in COVID-19 patients after 2 weeks of IMT. However, this study did not report on the five dimensions of QoL nor did they use a sham IMT (control group). IMT may not directly address or significantly influence dimensions such as mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, specifically in recovered COVID-19 patients after weaning from mechanical ventilation, who were critically ill previously. IMT may have a narrower scope of impact compared to interventions targeting these specific dimensions.

There were no time × group interaction effects for dyspnea and this was improved in both IMT and CON groups. Our dyspnea results are in accordance with a meta-analysis conducted by Figueiredo et al⁴⁸ in which they analyzed 12 studies on the effects of IMT in COPD patients and reported that IMT did not change dyspnea. Reductions in dyspnea were though greater in studies that conducted IMT for 8 weeks while studies with IMT durations of four to 6 weeks reported no significant improvement in dyspnea.⁴⁸ Thus, our IMT duration may not be long enough to elicit reductions in dyspnea.

Limitations

Due to the restricted availability of suitable patients, a smaller number of female patients were recruited, preventing the comparison of potential sex-related differences in outcome measures. Furthermore, the study had a limited duration of supervision and follow-up observation. Furthermore, the study had a limited duration of supervision and follow-up observation which is a limitation. As our study involved outpatient participants who visited the clinic at weekly intervals rather than daily, closely supervising their IMT or CON sessions in-person was not possible. We only monitored the appropriateness of the participants’ training technique and intensity during each of the participants first two visits to the hospital and intensity adjustments were not documented in training diaries. The duration of the study was limited to 4 weeks. This was because our study was a proof of concept of the effects of IMT in recovered COVID-19 patients after weaning from mechanical ventilation and there is evidence of adaptations to IMT after just 4 weeks.^30–32 In an ideal situation, the duration of the intervention would have lasted 8-12 weeks, and we would have more regular supervised training sessions which documented intensity adaptations during the intervention. Thus, it is essential to conduct randomized controlled trials with a larger patient cohort and an extended supervision and observation period for comprehensive evaluation. Additionally, early initiation of IMT during mechanical ventilation is recommended to prevent complications associated with post COVID sequalae and mechanical ventilation.

Conclusion

The present study found that 4 weeks of IMT results in a reduction of the muscle damage biomarkers slow sTnI and CKM. IMT also improved pulmonary function, inspiratory muscle strength and hand grip strength. The inclusion of IMT into the management of COVID-19 patients, particularly for intensive care patients, could assist with their recovery. Randomized controlled trials with a larger patient cohort and an extended supervision and observation period are required to support our findings.

Footnotes

Author contributions

E.W., B.H., D.E.M., conceived and designed the experiments; M.I., K.H, performed the experiments; M.I., D.E.M., analyzed the data; M.I., D.E.M. wrote the paper. E.W., B.H., D.E.M., reviewed the paper.

Declaration of conflicting interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the UniSQ International Research Scholarship, University of Southern Queensland.

ORCID iD

Muneeb Iqbal

References

Viana

Heubel

do Amaral

, et al. Can previous levels of physical activity affect risk factors for cardiorespiratory diseases and functional capacity after covid-19 hospitalization? A prospective cohort study. BioMed Res Int 2022; 2022: 7854303.

Hockele

Sachet Affonso

Rossi

, et al. Pulmonary and functional rehabilitation improves functional capacity, pulmonary function and respiratory muscle strength in post covid-19 patients: pilot clinical trial. Int J Environ Res Publ Health 2022; 19: 14899.

Sirayder

Inal-Ince

Kepenek-Varol

, et al. Long-term characteristics of severe covid-19: respiratory function, functional capacity, and quality of life. Int J Environ Res Publ Health 2022; 19: 6304.

Lentz

Roginski

Montrief

, et al. Initial emergency department mechanical ventilation strategies for covid-19 hypoxemic respiratory failure and ards. Am J Emerg Med 2020; 38: 2194–2202.

Gattinoni

Marini

Collino

, et al. The future of mechanical ventilation: lessons from the present and the past. Crit Care 2017; 21: 183.

Tobin

Laghi

Jubran

. Narrative review: ventilator-induced respiratory muscle weakness. Ann Intern Med 2010; 153: 240–245.

Daniel Martin

Smith

Gabrielli

. Mechanical ventilation, diaphragm weakness and weaning: a rehabilitation perspective. Respir Physiol Neurobiol 2013; 189: 377–383.

Cronin

Camporota

Formenti

. Mechanical ventilation in COVID-19: a physiological perspective. Exp Physiol 2022; 107: 683–693.

Reid

Clarke

Wallace

. Respiratory muscle injury: evidence to date and potential mechanisms. Can J Appl Physiol 2001; 26: 356–387.

10.

Dres

Goligher

Heunks

LMA

, et al. Critical illness-associated diaphragm weakness. Intensive Care Med 2017; 43: 1441–1452.

11.

Iqbal

Bliss

Whiteside

, et al. Biomarkers to measure respiratory muscle damage following inspiratory pressure threshold loading in healthy young men. J Appl Physiol 2023; 134: 1038–1046.

12.

Foster

Nakano

Sheel

, et al. Serum skeletal troponin I following inspiratory threshold loading in healthy young and middle-aged men. Eur J Appl Physiol 2012; 112: 3547–3558.

13.

Milner-Brown

Stein

Lee

. Synchronization of human motor units: possible roles of exercise and supraspinal reflexes. Electroencephalogr Clin Neurophysiol 1975; 38: 245–254.

14.

Gabriel

Kamen

Frost

. Neural adaptations to resistive exercise: mechanisms and recommendations for training practices. Sports Med 2006; 36: 133–149.

15.

Abodonya

Abdelbasset

Awad

, et al. Inspiratory muscle training for recovered covid-19 patients after weaning from mechanical ventilation: a pilot control clinical study. Medicine (Baltim) 2021; 100: e25339.

16.

Norton

. Pre-exercise screening: Guide to the australian adult pre-exercise screening system. Exercise and sport science australia, fitness australia and sports medicine australia. 2011.

17.

Altman

Bland

. Treatment allocation by minimisation. Bmj 2005; 330: 843.

18.

Fletcher

Elmes

Fairbairn

, et al. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959; 2: 257–266.

19.

Miller

Hankinson

Brusasco

, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319–338.

20.

Mills

Johnson

McPhilimey

, et al. The effects of inspiratory muscle training on plasma interleukin-6 concentration during cycling exercise and a volitional mimic of the exercise hyperpnea. J Appl Physiol 2013; 115: 1163–1172.

21.

Quanjer

Stanojevic

Cole

, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012; 40: 1324–1343.

22.

Wilson

Cooke

Edwards

, et al. Predicted normal values for maximal respiratory pressures in caucasian adults and children. Thorax 1984; 39: 535–538.

23.

Ringbaek

Brøndum

Martinez

, et al. Euroqol in assessment of the effect of pulmonary rehabilitation copd patients. Respir Med 2008; 102: 1563–1567.

24.

Euroqol-a new facility for the measurement of health-related quality of life. Health Pol 1990; 16: 199–208.

25.

Hillman

Nunes

Hornby

, et al. A practical posture for hand grip dynamometry in the clinical setting. Clin Nutr 2005; 24: 224–228.

26.

Vaidya

de Bisschop

Beaumont

, et al. Is the 1-minute sit-to-stand test a good tool for the evaluation of the impact of pulmonary rehabilitation? Determination of the minimal important difference in copd. Int J Chronic Obstr Pulm Dis 2016; 11: 2609–2616.

27.

Ats statement . Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111–117.

28.

Brooks

Solway

Gibbons

. Ats statement on six-minute walk test. Am J Respir Crit Care Med 2003; 167: 1287.

29.

Rao

Irfan

Haque

, et al. Six-minute walk test performance in healthy adult pakistani volunteers. J Coll Physicians Surg Pak 2013; 23: 720–725.

30.

Romer

McConnell

. Specificity and reversibility of inspiratory muscle training. Med Sci Sports Exerc 2003; 35: 237–244.

31.

Edwards

Maguire

Graham

, et al. Four weeks of inspiratory muscle training improves self-paced walking performance in overweight and obese adults: a randomised controlled trial. J Obes 2012; 2012: 918202.

32.

Notter

Verges

Renggli

, et al. Similar effects on exercise performance following different respiratory muscle training programs in healthy young men. Sci Rep 2023; 13: 16135.

33.

Spadaro

Dalla Corte

Scaramuzzo

, et al. Circulating skeletal troponin during weaning from mechanical ventilation and their association to diaphragmatic function: a pilot study. Front Med 2021; 8: 770408.

34.

Friedman

Charmchi

Silver

, et al. Skeletal muscle manifestations and creatine kinase in covid-19. Neurohospitalist 2022; 12: 597–606.

35.

Ganguly

. Levels of c-reactive protein, creatine kinase-muscle and aldolase a are suitable biomarkers to detect the risk factors for osteoarthritic disorders: a novel diagnostic protocol. Caspian J Intern Med 2019; 10: 25–35.

36.

Bissett

Leditschke

Paratz

, et al.

Respiratory dysfunction in ventilated patients: can inspiratory muscle training help?

Anaesth Intensive Care 2012; 40: 236–246.

37.

Ibrahim

Alkandari

Shady

IAA

, et al. Invasive mechanical ventilation complications in covid-19 patients. Egypt J Radiol Nucl Med 2021; 52(1): 226.

38.

Arruda

Peixoto

Callegaro

, et al. Effects of inspiratory muscle training in type 2 diabetes: a systematic review. Braz J Cardiovasc Surg 2023; 38: e20220366.

39.

Lista-Paz

Bouza Cousillas

Jácome

, et al. Effect of respiratory muscle training in asthma: a systematic review and meta-analysis. Ann Phys Rehabil Med 2023; 66: 101691.

40.

Ramirez-Sarmiento

Orozco-Levi

Guell

, et al. Inspiratory muscle training in patients with chronic obstructive pulmonary disease: structural adaptation and physiologic outcomes. Am J Respir Crit Care Med 2002; 166: 1491–1497.

41.

American Thoracic Society/European Respiratory Society statement . Ats/ers statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002; 166: 518–624. doi:10.1164/rccm.166.4.518.

42.

Mills

Johnson

Barnett

, et al. The effects of inspiratory muscle training in older adults. Med Sci Sports Exerc 2015; 47: 691–697.

43.

Shei

Paris

Wilhite

, et al. The role of inspiratory muscle training in the management of asthma and exercise-induced bronchoconstriction. Physician Sportsmed 2016; 44: 327–334.

44.

Decramer

. Response of the respiratory muscles to rehabilitation in copd. J Appl Physiol 2009; 107: 971–976.

45.

Severin

Franz

Farr

, et al. The effects of covid-19 on respiratory muscle performance: making the case for respiratory muscle testing and training. Eur Respir Rev 2022; 31: 220006.

46.

Janssens

McConnell

Pijnenburg

, et al. Inspiratory muscle training affects proprioceptive use and low back pain. Med Sci Sports Exerc 2015; 47: 12–19.

47.

Ferraro

Gavin

Wainwright

, et al. The effects of 8 weeks of inspiratory muscle training on the balance of healthy older adults: a randomized, double-blind, placebo-controlled study. Phys Rep 2019; 7: e14076.

48.

Figueiredo

RIN

Azambuja

Cureau

, et al. Inspiratory muscle training in COPD. Respir Care 2020; 65: 1189–1201.

The effects of inspiratory muscle training on biomarkers of muscle damage in recovered COVID-19 patients after weaning from mechanical ventilation

Abstract

Keywords

Introduction

Methods

Participants

Experimental design

Anthropometrics

Respiratory function

Quality of life, handgrip strength, sit to stand and six-minute walk test

Blood sampling and enzyme-linked immunosorbent assays

Inspiratory muscle training and control interventions

Statistical analysis

Results

Participant characteristics

Respiratory function and functional capacity

Quality of life and dyspnea

Muscle damage biomarkers

Discussion

Main findings

Muscle damage biomarkers

Respiratory function

Functional capacity

Quality of life and dyspnea

Limitations

Conclusion

Footnotes

Author contributions

Declaration of conflicting interests

Funding

ORCID iD

References